In March 2025, the company announced new designs to get a direct-to-shopper providing of its Wegovy weight loss drug. The company recognized a brand new pharmacy, identified as NovoCare, which would cost shoppers $499 each month for entry to the drug, fewer than fifty percent the expense of the drug by means of other pharmaceutical distribution net